Shiba Inu is demonstrating a mix of strengthening price momentum and moderate exchange activity, potentially creating favorable conditions for continued gains. The token is currently priced near $0.00000592, with only around 20 billion SHIB marking the net exchange balance over the past 24 hours.
Shiba Inu trades near $0.00000592 with stable exchange reserves and improving price
Active flows, stable reserves
Data for the recent period highlights contrasting movements in gross exchange flows. Inflows to trading platforms reached nearly 623.3 billion SHIB, while outflows totaled approximately 449.8 billion SHIB, underscoring significant trading activity in both directions.
Despite these large numbers, total SHIB exchange reserves stand at about 87.83 trillion tokens, shifting by just 0.2% throughout the day. This stability suggests that while traders are active, there has not been a dramatic accumulation or distribution of SHIB on centralized platforms.
These patterns are closely monitored as exchange deposits often signal changes in available selling supply. The modest net increase in tradable SHIB has taken place alongside the token’s rebound, a dynamic that market observers watch for potential bullish continuation.
| SHIB Price | $0.00000592 | N/A |
| Exchange Inflows | 623.3 billion SHIB | N/A |
| Exchange Outflows | 449.8 billion SHIB | N/A |
| Exchange Reserves | 87.83 trillion SHIB | +0.2% |
| Net Exchange Balance | 20 billion SHIB | N/A |
Technical levels and recovery
Shiba Inu’s price structure has improved since bottoming at $0.0000041 in July, gradually forming higher lows and advancing past $0.0000055. The latest upward move briefly lifted SHIB above $0.0000062 before increased volatility emerged.
The token’s current trading level sits above a long-term moving average, which had previously acted as resistance at $0.0000056–$0.0000057. This technical feature now provides a potential foundation for further upside, contingent on the price maintaining support above that threshold.
Shiba Inu is holding above the major long-term moving average near $0.0000056–$0.0000057, an area that acted as resistance before. Sustaining this level is seen as important for confirming the ongoing recovery trend.
Short-term momentum appears constructive, with the daily relative strength index (RSI) in the low-60s—a region below traditional overbought readings. Immediate resistance is located at $0.0000060–$0.0000063. A decisive move through this zone could open the path toward the May trading area of $0.0000065–$0.0000067.
Risks from exchange flows
The main risk remains a sudden increase in SHIB deposits to exchanges. Although netflow is currently positive, the magnitude of movement is small when compared with the overall supply and existing reserves. The absence of sharp increases in exchange balances indicates that market structure, rather than deposit trends, may continue to influence price direction.
While SHIB’s net exchange flow is currently positive, its scale has been moderate relative to the token’s total circulating supply and reserves. As long as exchange balances remain stable, price structure is likely to be the key factor for short-term market sentiment.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AI financing concerns weigh heavily on chip stocks, global tech sector has lost over $1 trillion this week
Multiple pressures, including rising expectations of a Federal Reserve rate hike and increasing AI financing costs, have led to a massive sell-off in global tech stocks this week. The combined market value of the world's top 20 AI and semiconductor stocks has evaporated by more than $1 trillion, and the semiconductor ETF (SOXX) has recorded its longest losing streak in 11 years. On Thursday, SK Hynix continued to plunge by over 10% in a single day, while Nvidia, Samsung, and SoftBank were not spared.
Safe Haven Amid AI Crash! Major Pharmaceutical Stocks Approach Historic Highs
Amid concerns over AI capital expenditures, funds are seeking a "certainty premium." State Street Healthcare ETF reached a record high. Eli Lilly and AbbVie are both approaching their historical highest closing prices, while Gilead and Amgen have surged 7.7% and 7.2% respectively over the past five days. Eli Lilly continues to bet on the future through its GLP-1 dominance and 40 M&A deals totaling $20 billion. AbbVie's core drug Skyrizi has shown positive data for its new subcutaneous formulation, which is expected to extend its patent and drive additional sales.

Fed Officials Turn Hawkish: Daly Says Supply Shocks Should No Longer Be "Wait-and-See," Hammack Suggests More Aggressive Rate Hikes May Be Needed if Inflation Expectations Become Entrenched
San Francisco Fed President Daly stated that the traditional "wait and see" approach to supply-side shocks has been abandoned, noting that businesses in her district are tending to pass rising costs on to consumers and that current inflation risks are "skewed fully to the upside." Cleveland Fed President Hammack said that once the public forms an "inflationary mindset," the difficulty of monetary policy regulation will increase significantly, and the required interest rate hikes will then exceed expectations.

Australian Dollar crumbles as job losses shatter RBA rate hike hopes

